Effects of Short Isokinetic Eccentric Resistance Training on Neuromuscular Induced Adaptations (NCT07407621) | Clinical Trial Compass
By InvitationNot Applicable
Effects of Short Isokinetic Eccentric Resistance Training on Neuromuscular Induced Adaptations
Malaysia24 participantsStarted 2025-01-02
Plain-language summary
The study compares the impact of isokinetic resistance training (RT) -induced neuromuscular adaptation following an 8-week short ECC ISO RT and CON ISO RT among obese, untrained women. The main question it aims to answer is:
1\. Does exercise-induced neuromuscular adaptation following progressive short ECC ISO RT, more effectively than CON ISO RT, among obese, untrained women?
Researchers will compare drug ECCISO RT to a CONISO RT to see if ECCISO RT is more effective in inducing neuro-muscular adaptations in obese, untrained women.
Participants will:
1. Train on isokinetic ECC or CON for 8 weeks
2. Visit the clinic twice for baseline and post tests
Who can participate
Age range
18 Years – 45 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
INCLUSION CRITERIA:
* Eumenorrheic women (reporting menstrual cycle between 21-35 days)
* Age 25-45 y/o
* BMI \> 23.0 kg/m2
* Body fat percentage \> 30%
* No lower limb orthopaedic injuries
* Have not participated in any structured/ unstructured weight loss intervention in the past 12 months
* Sedentary lifestyle (regular exercise \<1 hour per week)
* Stable body weight (loss or gain of no greater than 2 kg)
* Stable medication use for six months before enrolment
EXCLUSION CRITERIA:
* smokers
* taking supplements or medication known to affect REE (such as oral contraceptives)
* severe medical conditions affecting their physical or mental health
* individuals with an implanted medical device
* suffer from alcohol or drug abuse
* trying to conceive/ pregnant, or breastfeeding
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.